research and development news

Showing 15 posts of 28 posts found.

Quintiles opens new European headquarters in the UK

October 12, 2011
Research and Development Quintiles, research and development news

Pharmaceutical services company Quintiles has opened a new European headquarters in the UK. The Reading, Berkshire facility will house more …

Contract research news in brief

October 5, 2011
Research and Development research and development news

Clinipace raises $15m, PPD appoints a new chief executive and there are updates from Quintiles, PharmaNet and DaVita Clinical Research. …

GSK McLaren

McLaren alliance to turbocharge GSK research

September 16, 2011
Manufacturing and Production, Research and Development GSK, manufacturing and production news, pharma manufacturing news, research and development news

GlaxoSmithKline has turned to the engineering expertise of Formula 1 racing team McLaren in an innovative alliance designed to transform …

Clinical research news in brief

September 8, 2011
Research and Development research and development news

This roundup includes using social media to recruit trial subjects, a strategic level service deal between BMS and Icon, plus …

Eisai shares risk with novel trial funding approach

September 7, 2011
Research and Development Eisai, clinical trials, research and development news

Eisai has unveiled a novel risk-sharing approach to accelerate its late-stage research programme by accepting new sources of clinical trial …

EMA

EMA should compare ‘like-for-like’ when assessing new drugs

September 7, 2011
Research and Development EMA, clnical trials, research and development news

The European system of comparing drugs against placebo and not against a comparator is flawed, according to a new LSE …

Lilly considering a stake in Turkish drugmaker

September 6, 2011
Manufacturing and Production, Research and Development, Sales and Marketing MN Pharmaceuticals, Turkey, lilly, research and development news

Eli Lilly is reportedly eyeing up a partnership with Turkish drugmaker Mustafa Nevzat Ilac Sanayi (MN Pharmaceuticals) in order to …

Zonegran study could pave way for paediatric licence

September 2, 2011
Research and Development, Sales and Marketing Eisai, Zonegran, epilepsy, research and development news

Eisai’s epilepsy drug Zonegran has been found more effective than placebo in children with the neurological condition who have seizures. …

Pfizer Sandwich Kent

Ex-Pfizer employees set up new business at Sandwich

September 1, 2011
Research and Development Pfizer, Sandwich, The Research Network, research and development news

Seven former Pfizer employees have set up a new business in Sandwich that will provide outsourcing services for the pharma …

Clinical research news in brief

August 24, 2011
Research and Development contract research news, research and development news

Private equity firm the Carlyle Group is rumoured to be looking at buying PPD, plus there are updates from CTA/Clininvent, …

UK research receives £800m funding boost

August 23, 2011
Research and Development NIHR, UK research, UK science, research and development news

Research into dementia, cancer, diabetes and heart disease are among the activities to benefit from a new £800 government funding …

GlaxoSmithKline

GSK invests in UK biotech start-up

August 22, 2011
Research and Development Autifony, GSK, biotech, hearing loss, research and development news

GlaxoSmithKline has taken a £1.3 million stake in a new UK biotech spin-out that will develop pharmacological treatments for hearing …

Contract research news in brief

August 17, 2011
Research and Development research and development news

Our round-up of news from the contract research sector includes the rejection of a cancer drug by the FDA because …

Onyx Scientific bought by India’s Ipca Labs

August 16, 2011
Manufacturing and Production, Research and Development Ipca, Onyx, contract research news, pharma manufacturing news, research and development news

India’s Ipca Laboratories has bought UK chemistry services firm Onyx Scientific for around £4.6 million ($7.5m). The Mumbai-based company, a …

GlaxoSmithKline

GSK Parkinson’s drug shows motor skills benefits

August 16, 2011
Research and Development GSK, Impax Pharmaceuticals, Parkinson's disease, research and development news

GlaxoSmithKline’s new drug IPX066 has helped Parkinson’s disease patients retain their motor skills after their medication wore off. IPX066, which …

Latest content